{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:40:14Z","timestamp":1776692414037,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T00:00:00Z","timestamp":1496620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/leu.2017.174","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T08:47:00Z","timestamp":1496652420000},"page":"49-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"32","author":[{"given":"S","family":"Tharkar-Promod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D P","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S E","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B G","family":"Banowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S S","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"Shearstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S N","family":"Quayle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Jarpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Mosbruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D","family":"Pomicter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R R","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K N","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"Zweidler-McKay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D C","family":"Shrieve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M W","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M B","family":"Chandrasekharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bhaskara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,5]]},"reference":[{"key":"BFleu2017174_CR1","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1172\/JCI33032","volume":"117","author":"GA Koretzky","year":"2007","unstructured":"Koretzky GA . The legacy of the Philadelphia chromosome. J Clin Invest 2007; 117: 2030\u20132032.","journal-title":"J Clin Invest"},{"key":"BFleu2017174_CR2","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1172\/JCI61203","volume":"122","author":"CG Mullighan","year":"2012","unstructured":"Mullighan CG . Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3407\u20133415.","journal-title":"J Clin Invest"},{"key":"BFleu2017174_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3324\/haematol.2014.118588","volume":"100","author":"N Daver","year":"2015","unstructured":"Daver N, Thomas D, Ravandi F, Cortes J, Garris R, Jabbour E et al. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 2015; 100: 653\u2013661.","journal-title":"Haematologica"},{"key":"BFleu2017174_CR4","first-page":"243","volume":"8","author":"GD Miller","year":"2014","unstructured":"Miller GD, Bruno BJ, Lim CS . Resistant mutations in CML and Ph(+)ALL - role of ponatinib. Biologics 2014; 8: 243\u2013254.","journal-title":"Biologics"},{"key":"BFleu2017174_CR5","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","volume":"21","author":"HZ Lee","year":"2015","unstructured":"Lee HZ, Kwitkowski VE, Del Valle PL, Ricci MS, Saber H, Habtemariam BA et al. FDA approval: belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Clin Cancer Res 2015; 21: 2666\u20132670.","journal-title":"Clin Cancer Res"},{"key":"BFleu2017174_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11912-012-0247-7","volume":"14","author":"T Liu-Dumlao","year":"2012","unstructured":"Liu-Dumlao T, Kantarjian H, Thomas DA, O'Brien S, Ravandi F . Philadelphia-positive acute lymphoblastic leukemia: current treatment options. Curr Oncol Rep 2012; 14: 387\u2013394.","journal-title":"Curr Oncol Rep"},{"key":"BFleu2017174_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2010\/920161","volume":"2010","author":"M Podhorecka","year":"2010","unstructured":"Podhorecka M, Skladanowski A, Bozko P . H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucleic Acids 2010; 2010: 1\u20139.","journal-title":"J Nucleic Acids"},{"key":"BFleu2017174_CR8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/onc.2012.203","volume":"32","author":"LA Tobin","year":"2013","unstructured":"Tobin LA, Robert C, Rapoport AP, Gojo I, Baer MR, Tomkinson AE et al. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene 2013; 32: 1784\u20131793.","journal-title":"Oncogene"},{"key":"BFleu2017174_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2010-09-307256","volume":"118","author":"A Slupianek","year":"2011","unstructured":"Slupianek A, Dasgupta Y, Ren SY, Gurdek E, Donlin M, Nieborowska-Skorska M et al. Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia. Blood 2011; 118: 1062\u20131068.","journal-title":"Blood"},{"key":"BFleu2017174_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2006-08-042630","volume":"110","author":"L Rink","year":"2007","unstructured":"Rink L, Slupianek A, Stoklosa T, Nieborowska-Skorska M, Urbanska K, Seferynska I et al. Enhanced phosphorylation of Nbs1, a member of DNA repair\/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR\/ABL-positive leukemia cells. Blood 2007; 110: 651\u2013660.","journal-title":"Blood"},{"key":"BFleu2017174_CR11","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.1038\/sj.onc.1206087","volume":"21","author":"T Skorski","year":"2002","unstructured":"Skorski T . BCR\/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability. Oncogene 2002; 21: 8591\u20138604.","journal-title":"Oncogene"},{"key":"BFleu2017174_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","volume":"12","author":"BS Mann","year":"2007","unstructured":"Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R . FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 2007; 12: 1247\u20131252.","journal-title":"Oncologist"},{"key":"BFleu2017174_CR13","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","volume":"98","author":"RL Piekarz","year":"2001","unstructured":"Piekarz RL, Robey R, Sandor V, Bakke S, Wilson WH, Dahmoush L et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood 2001; 98: 2865\u20132868.","journal-title":"Blood"},{"key":"BFleu2017174_CR14","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","volume":"21","author":"JP Laubach","year":"2015","unstructured":"Laubach JP, Moreau P, San-Miguel JF, Richardson PG . Panobinostat for the treatment of multiple myeloma. Clin Cancer Res 2015; 21: 4767\u20134773.","journal-title":"Clin Cancer Res"},{"key":"BFleu2017174_CR15","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1158\/1078-0432.CCR-06-1017","volume":"12","author":"SE Bates","year":"2006","unstructured":"Bates SE, Rosing DR, Fojo T, Piekarz RL . Challenges of evaluating the cardiac effects of anticancer agents. Clin Cancer Res 2006; 12: 3871\u20133874.","journal-title":"Clin Cancer Res"},{"key":"BFleu2017174_CR16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/1078-0432.CCR-05-2689","volume":"12","author":"MH Shah","year":"2006","unstructured":"Shah MH, Binkley P, Chan K, Xiao J, Arbogast D, Collamore M et al. Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors. Clin Cancer Res 2006; 12: 3997\u20134003.","journal-title":"Clin Cancer Res"},{"key":"BFleu2017174_CR17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1080\/15384101.2015.1042634","volume":"14","author":"S Bhaskara","year":"2015","unstructured":"Bhaskara S . Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers. Cell Cycle 2015; 14: 1779\u20131785.","journal-title":"Cell Cycle"},{"key":"BFleu2017174_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","volume":"30","author":"S Bhaskara","year":"2008","unstructured":"Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW et al. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell 2008; 30: 61\u201372.","journal-title":"Mol Cell"},{"key":"BFleu2017174_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4161\/cc.10.5.14866","volume":"10","author":"S Bhaskara","year":"2011","unstructured":"Bhaskara S, Hiebert SW . Role for histone deacetylase 3 in maintenance of genome stability. Cell Cycle 2011; 10: 727\u2013728.","journal-title":"Cell Cycle"},{"key":"BFleu2017174_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1756-8935-6-27","volume":"6","author":"S Bhaskara","year":"2013","unstructured":"Bhaskara S, Jacques V, Rusche JR, Olson EN, Cairns BR, Chandrasekharan MB . Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression. Epigenetics Chromatin 2013; 6: 27.","journal-title":"Epigenetics Chromatin"},{"key":"BFleu2017174_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ccr.2010.10.022","volume":"18","author":"S Bhaskara","year":"2010","unstructured":"Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S et al. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 2010; 18: 436\u2013447.","journal-title":"Cancer Cell"},{"key":"BFleu2017174_CR22","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.18632\/oncotarget.3120","volume":"6","author":"DP Johnson","year":"2015","unstructured":"Johnson DP, Spitz GS, Tharkar S, Quayle SN, Shearstone JR, Jones S et al. HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma. Oncotarget 2015; 6: 4863\u20134887.","journal-title":"Oncotarget"},{"key":"BFleu2017174_CR23","doi-asserted-by":"publisher","first-page":"e0153767","DOI":"10.1371\/journal.pone.0153767","volume":"11","author":"JR Shearstone","year":"2016","unstructured":"Shearstone JR, Golonzhka O, Chonkar A, Tamang D, van Duzer JH, Jones SS et al. Chemical inhibition of histone deacetylases 1 and 2 induces fetal hemoglobin through activation of GATA2. PLoS One 2016; 11: e0153767.","journal-title":"PLoS One"},{"key":"BFleu2017174_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/onc.2012.83","volume":"32","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yuan H, Roth M, Stark JM, Bhatia R, Chen WY . SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells. Oncogene 2013; 32: 589\u2013598.","journal-title":"Oncogene"},{"key":"BFleu2017174_CR25","first-page":"84","volume":"1845","author":"F Yang","year":"2014","unstructured":"Yang F, Teves SS, Kemp CJ, Henikoff S . Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta 2014; 1845: 84\u201389.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu2017174_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1242\/jcs.159103","volume":"128","author":"W Qi","year":"2015","unstructured":"Qi W, Wang R, Chen H, Wang X, Xiao T, Boldogh I et al. BRG1 promotes the repair of DNA double-strand breaks by facilitating the replacement of RPA with RAD51. J Cell Sci 2015; 128: 317\u2013330.","journal-title":"J Cell Sci"},{"key":"BFleu2017174_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molcel.2014.06.028","volume":"55","author":"A Kakarougkas","year":"2014","unstructured":"Kakarougkas A, Ismail A, Chambers AL, Riballo E, Herbert AD, Kunzel J et al. Requirement for PBAF in transcriptional repression and repair at DNA breaks in actively transcribed regions of chromatin. Mol Cell 2014; 55: 723\u2013732.","journal-title":"Mol Cell"},{"key":"BFleu2017174_CR28","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1128\/MCB.26.7.2661-2674.2006","volume":"26","author":"A Klochendler-Yeivin","year":"2006","unstructured":"Klochendler-Yeivin A, Picarsky E, Yaniv M . Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5\/Ini1 subunit of the SWI\/SNF chromatin remodeling complex. Mol Cell Biol 2006; 26: 2661\u20132674.","journal-title":"Mol Cell Biol"},{"key":"BFleu2017174_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2015.02.031","volume":"58","author":"YH Chen","year":"2015","unstructured":"Chen YH, Jones MJ, Yin Y, Crist SB, Colnaghi L, Sims RJ 3rd et al. ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress. Mol Cell 2015; 58: 323\u2013338.","journal-title":"Mol Cell"},{"key":"BFleu2017174_CR30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.celrep.2014.10.018","volume":"9","author":"DA Orlando","year":"2014","unstructured":"Orlando DA, Chen MW, Brown VE, Solanki S, Choi YJ, Olson ER et al. Quantitative ChIP-Seq normalization reveals global modulation of the epigenome. Cell Rep 2014; 9: 1163\u20131170.","journal-title":"Cell Rep"},{"key":"BFleu2017174_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2217\/epi.13.13","volume":"5","author":"X Dong","year":"2013","unstructured":"Dong X, Weng Z . The correlation between histone modifications and gene expression. Epigenomics 2013; 5: 113\u2013116.","journal-title":"Epigenomics"},{"key":"BFleu2017174_CR32","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.cell.2013.02.011","volume":"152","author":"BD Price","year":"2013","unstructured":"Price BD, D'Andrea AD . Chromatin remodeling at DNA double-strand breaks. Cell 2013; 152: 1344\u20131354.","journal-title":"Cell"},{"key":"BFleu2017174_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1631\/jzus.B1400077","volume":"15","author":"RG Ma","year":"2014","unstructured":"Ma RG, Zhang Y, Sun TT, Cheng B . Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins. J Zhejiang Univ Sci B 2014; 15: 412\u2013428.","journal-title":"J Zhejiang Univ Sci B"},{"key":"BFleu2017174_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman JR, Taylor MR, Boulton SJ . Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 2012; 47: 497\u2013510.","journal-title":"Mol Cell"},{"key":"BFleu2017174_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.cell.2010.05.035","volume":"141","author":"MS Huen","year":"2010","unstructured":"Huen MS, Chen J . ATM creates a veil of transcriptional silence. Cell 2010; 141: 924\u2013926.","journal-title":"Cell"},{"key":"BFleu2017174_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.cell.2010.04.038","volume":"141","author":"NM Shanbhag","year":"2010","unstructured":"Shanbhag NM, Rafalska-Metcalf IU, Balane-Bolivar C, Janicki SM, Greenberg RA . ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. Cell 2010; 141: 970\u2013981.","journal-title":"Cell"},{"key":"BFleu2017174_CR37","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gad.1563807","volume":"21","author":"RL Montgomery","year":"2007","unstructured":"Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 2007; 21: 1790\u20131802.","journal-title":"Genes Dev"},{"key":"BFleu2017174_CR38","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010; 363: 552\u2013563.","journal-title":"N Engl J Med"},{"key":"BFleu2017174_CR39","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1016\/j.febslet.2010.07.029","volume":"584","author":"BJ Lamarche","year":"2010","unstructured":"Lamarche BJ, Orazio NI, Weitzman MD . The MRN complex in double-strand break repair and telomere maintenance. FEBS Lett 2010; 584: 3682\u20133695.","journal-title":"FEBS Lett"},{"key":"BFleu2017174_CR40","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nsmb0809-798","volume":"16","author":"S Zha","year":"2009","unstructured":"Zha S, Boboila C, Alt FW . Mre11: roles in DNA repair beyond homologous recombination. Nat Struct Mol Biol 2009; 16: 798\u2013800.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu2017174_CR41","doi-asserted-by":"publisher","first-page":"a012740","DOI":"10.1101\/cshperspect.a012740","volume":"5","author":"M Jasin","year":"2013","unstructured":"Jasin M, Rothstein R . Repair of strand breaks by homologous recombination. Cold Spring Harb Perspect Biol 2013; 5: a012740.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"BFleu2017174_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0968-0004(98)01232-8","volume":"23","author":"P Baumann","year":"1998","unstructured":"Baumann P, West SC . Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci 1998; 23: 247\u2013251.","journal-title":"Trends Biochem Sci"},{"key":"BFleu2017174_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jmcb\/mjq048","volume":"3","author":"L Zheng","year":"2011","unstructured":"Zheng L, Shen B . Okazaki fragment maturation: nucleases take centre stage. J Mol Cell Biol 2011; 3: 23\u201330.","journal-title":"J Mol Cell Biol"},{"key":"BFleu2017174_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.dnarep.2005.02.004","volume":"4","author":"JD Goetz","year":"2005","unstructured":"Goetz JD, Motycka TA, Han M, Jasin M, Tomkinson AE . Reduced repair of DNA double-strand breaks by homologous recombination in a DNA ligase I-deficient human cell line. DNA Repair 2005; 4: 649\u2013654.","journal-title":"DNA Repair"},{"key":"BFleu2017174_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fgene.2014.00296","volume":"5","author":"NC House","year":"2014","unstructured":"House NC, Koch MR, Freudenreich CH . Chromatin modifications and DNA repair: beyond double-strand breaks. Front Genet 2014; 5: 296.","journal-title":"Front Genet"},{"key":"BFleu2017174_CR46","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA et al. Super-enhancers in the control of cell identity and disease. Cell 2013; 155: 934\u2013947.","journal-title":"Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2017174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017174","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:07:48Z","timestamp":1684433268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFleu2017174"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.174","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,5]]},"assertion":[{"value":"14 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SNQ, JRS and CM were employees of and owned equity in Acetylon Pharmaceuticals. SSJ and MJ are current employees of Regenacy Pharmaceuticals. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}